Point mutation (-69 G→A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 6, 2001, Pages 985-990

  Nagano, Makoto ^a   Yamashita, Shizuya ^a   Hirano, Ken Ichi ^a   Kujiraoka, Takeshi ^a   Ito, Mayumi ^a   Sagehashi, Yukiko ^a   Hattori, Hiroaki ^a   Nakajima, Norimichi ^a   Maruyama, Takao ^a   Sakai, Naohiko ^a   Egashira, Tohru ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cholesteryl ester transfer protein deficiency; Hyperalphalipoproteinemia; Mutation; PEA3 ETS binding site; Promoter

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL ESTER; CHOLESTEROL ESTER TRANSFER PROTEIN; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BINDING SITE; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE MUTATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HYPERALPHALIPOPROTEINEMIA; HYPERLIPOPROTEINEMIA; JAPAN; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0035718873     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.21.6.985     Document Type: Article

References (35)

1. Plasma lipid transfer protein
2. Molecular genetics of plasma cholesteryl ester transfer protein
3. Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: Plasma CETP regulates high-density lipoprotein concentration and composition
4. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins
5. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation
6. Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect
7. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol
8. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population: Relation between the mutation and hyperalphalipoproteinemia
9. A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins
10. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects
11. Small polydisperse low density lipoproteins in familial hyperalphalipoproteinemia with complete deficiency of cholesteryl ester transfer activity
12. Detection of two species of low density lipoprotein particles in cholesteryl ester transfer protein deficiency
13. Decreased affinity of low density lipoprotein (LDL) particles for LDL receptors in patients with cholesteryl ester transfer protein deficiency
14. Large and cholesteryl ester-rich high-density lipoproteins in cholesteryl ester transfer protein (CETP) deficiency can not protect macrophages from cholesterol accumulation induced by acetylated low-density lipoproteins
15. Pathophysiology of reverse cholesterol transport: Insights from inherited disorders of lipoprotein metabolism
16. Plasma lipid transfer protein, high-density lipoproteins, and reverse cholesterol transport
17. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan
18. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels
19. The determination and chemical composition of ultracentrifugally separated lipoproteins in human serum
20. Purification, microheterogeneity, and stability of human lipid transfer protein
21. Secretion of preβ HDL increases with the suppression of cholesteryl ester transfer protein in HepG2 cells
22. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects
23. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA
24. Exon 10 skipping caused by intron 10 splicing donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection
25. Estimation of the concentration of the low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
26. Human cholesteryl ester transfer protein gene proximal promoter contains dietary cholesterol positive responsive elements and mediates expression in small intestine and periphery while predominant liver and spleen expression is controlled by 5′-distal sequences
27. Cloning and sequencing of the human cholesteryl ester transfer protein cDNA
28. Cholesteryl ester transfer protein is secreted by HepG2 cells and contains asparagine-linked carbohydrate and sialic acid
29. Synthesis and secretion of plasma cholesteryl ester transfer protein by human hepatocarcinoma cell line, HepG2
30. Specificity within the ets family of transcription factors
31. Congenital myasthenic syndrome caused by a mutation in the Ets-binding site of the promoter region of the acetyl-choline receptor epsilon subunit gene
32. Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
33. Transcriptional regulation of the cholesteryl ester transfer protein gene by the orphan nuclear hormone receptor apolipoprotein AI regulatory protein-1
34. Identification of retinoic acid receptor element in human cholesteryl ester transfer protein gene
35. Influence of the high density lipoprotein receptor SR-B1 on reproductive and cardiovascular pathophysiology